The Structural Formula For Benzonatate, A Non-narcotic Antitussive Agent, Is 2, 5, 8, 11, 14, 17, 20, 23, 26- Nonaoxaoctacosan-28-yl P-(butylamino) Benzoate; With A Molecular Weight Of 603.7. (Benzonatate Capsules 01)
Benzonatate
Product Images NDC 10135-632
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 10135-632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panelbenzonatatecapsules, Usp200 mg500 Capsulesrx Only (Benzonatate Capsules 02)
This is a medication called Benzonatate which is usually taken as per the information provided in the package outsert. Each capsule includes 200 mg of Benzonatate, USP. The medication should be stored between 20° to 25°C (68° to 77°F) excursions. It is suggested to keep the capsules tightly closed and protect them from light by storing them in a light-resistant container as defined by USP guidelines. This medication is produced by a company called Wearkex Phamacescals, Inc located in New Castle, DE. This specific package contains 500 capsules, and the revision date is October 2017.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
